Abstract
In Duchenne Muscular Dystrophy (DMD), progressive accumulation of cardiac fibrosis promotes heart failure. While the cellular origins of fibrosis in DMD hearts remain enigmatic, fibrotic tissue conspicuously forms near the coronary adventitia. Therefore, we sought to characterize the role of coronary adventitial cells in the formation of perivascular fibrosis. Utilizing the mdx model of DMD, we have identified a population of Sca1+, PDGFRα+, CD31−, CD45− coronary adventitial cells responsible for perivascular fibrosis. Histopathology of dystrophic hearts revealed Sca1+ cells extend from the adventitia and occupy regions of perivascular fibrosis. The number of Sca1+ adventitial cells increased two-fold in fibrotic mdx hearts vs. age matched wild-type hearts. Moreover, relative to Sca1−, PDGFRα+, CD31−, CD45− cells and endothelial cells, Sca1+ adventitial cells FACS-sorted from mdx hearts expressed the highest level of Collagen1α1 and 3α1, Connective tissue growth factor, and Tgfβr1 transcripts. Surprisingly, mdx endothelial cells expressed the greatest level of the Tgfβ1 ligand. Utilizing Collagen1α1-GFP reporter mice, we confirmed that the majority of Sca1+ adventitial cells expressed type I collagen, an abundant component of cardiac fibrosis, in both wt (71% ±4.1) and mdx (77% ±3.5) hearts. In contrast, GFP+ interstitial fibroblasts were PDGFRα+ but negative for Sca1. Treatment of cultured Collagen1α1-GFP+ adventitial cells with TGFβ1 resulted in increased collagen synthesis, whereas pharmacological inhibition of TGFβR1 signaling reduced the fibrotic response. Therefore, perivascular cardiac fibrosis by coronary adventitial cells may be mediated by TGFβ1 signaling. Our results implicate coronary endothelial cells in mediating cardiac fibrosis via transmural TGFβ signaling, and suggest that the coronary adventitia is a promising target for developing novel anti-fibrotic therapies.
Keywords: Muscular Dystrophy, fibrosis, TGFβ1, Sca1, type I collagen, perivascular, adventitia
1. Introduction
Duchenne Muscular Dystrophy (DMD) is a genetic X-linked disease characterized by the absence of the dystrophin protein and progressive muscle wasting [1, 2]. The majority of DMD patients develop cardiomyopathy and with the advent of ventilators, heart failure is emerging as the leading cause of mortality [3–5]. Cardiomyopathy in DMD is characterized by the accumulation of fibrosis which promotes heart dysfunction [6–8]. Perivascular fibrosis, described in many cardiac diseases processes including DMD, has been implicated in heart failure [9, 10]. Yet the cellular processes and molecular mechanisms that govern perivascular fibrosis in chronic diseases are poorly characterized [11]. By histopathology, the proximity of perivascular fibrosis to the coronary adventitia is difficult to overlook. Therefore, we set out to define the role of coronary adventitial cells in perivascular fibrosis. Utilizing the mdx mouse model of DMD [12], herein this report we have characterized a population of Sca1+, PDGFRα+, CD31−, CD45− cells that reside in the coronary adventitia, and produce collagen in proximity to perivascular fibrosis. Specifically, in mdx hearts we detected Sca1+ cells in regions of severe perivascular fibrosis. In turn, molecular analysis revealed that Sca1+ adventitial cells expressed significant levels of pro-fibrotic genes: Collagen1α1, Collagen3α1, Tgfβr1, and Connective tissue growth factor (Ctgf) [13–15]. Surprisingly, we observed that mdx endothelial cells expressed high levels of Tgfβ1 ligand suggesting that adventitial cells become fibrotic via transmural TGFβ1 signaling. Indeed, stimulation of FACS-sorted adventitial cells with TGFβ1 in vitro, resulted in increased collagen expression and deposition. In contrast, pharmacological inhibition of TGFβR1 with SB525334 [16], resulted a reduction of collagen synthesis. Altogether, our findings indicate adventitial cells are associated with perivascular fibrosis and TGFβ1 signaling induces a fibrotic response in these cells.
2. Materials and Methods
2.1. Animals
All animal experiments were done in accordance with Institutional Animal Case and Use Committee (IACUC) approved procedures. mdx animals harboring the Col1α1-GFP reporter allele were generated in house by mating a wt male heterozygous for Col1α1-GFP allele, with mdx females. Since dystrophin is x-linked, the resulting male progeny were all mdx with a Mendelian inheritance frequency of ½ for the Col1α1-GFP allele. All mice reported in this manuscript are under a C57BL/6 background (Supplement Table. S1).
2.2. Histology and Staining
For WGA labeling depicted in Fig. 1A, 11 month old Sca1-GFP males (n=3) were first anesthetized with 100μl per 10mg mouse weight, of 2.5% (w/v) avertin (Sigma-Aldrich, St.Louis, MO) in PBS. Following anesthesia, animals were injected intravenously with 100μl of 1mg/ml WGA-Rhodamine (Vector Labs, Burlingame, CA) in PBS and euthanized 5 minutes following injection. Post euthanasia, animals were perfused in the left ventricle, first with PBS followed by 4% formaldehyde. Hearts were then excised and incubated in 4% formaldehyde for 2 hours at room temperature. Following fixation, hearts were incubated in PBS with sucrose beginning with 10% (w/v) and 20%, each for 30 minutes at 4°C, then transferred to 30% sucrose and left overnight at 4°C. The following day Sca1-GFP hearts were frozen in OCT in isopentane cooled by liquid nitrogen to negative 150–160°C. Tissue fromPDGFRα-GFP and:Co1a1-GFP reporteranimals were fixed and processed in the same manner as Sca1-GFP hearts, but without perfusion. Hearts from non-GFP reporter mdx animals used for cardiac histology were all males ranging from 12–22 months of age. These hearts were freshly frozen without prior fixation or processing. For picrosirius staining, tissue was fixed with ice cold methanol for 5 minutes, then stained in saturated picric acid containing 0.1% (w/v) sirius red and 0.1% (w/v) fast green, for 1 hour at room temperature. Slides were then washed in acidified water, dehydrated with ethanol gradient of 70–100%, and cleared with four washes of xylene. Subsequent slides from the same hearts were used to correlate picrosirius red staining with antibody staining. For antibody staining tissue was fixed with 4% formaldehyde for 5 minutes, washed with PBS, and blocked with PBS containing 10% goat or horse serum if the secondary antibody was goat, and 1% BSA for 20 minutes, at room temperature. All antibodies were diluted in PBS with 1% BSA. Control staining was run in parallel using an IgG isotype antibody made in rat, goat or rabbit, and subsequent secondary antibodies. Antibody specifics and dilutions are listed in supplement table S2. Epifluorescent photographs were taken with an Axiocam mRM monochrome camera using a Zeiss Axiovert 200 microscope with previously described components [17]. Confocal photographs (Fig. 4) were taken with a Nikon A1R system located in the Lynn and Mike Garvey cell imaging lab, at the University of Washington’s Institute for Stem Cell and Regenerative Medicine (ISCRM imaging core). Channels were subsequently colored and merged using Adobe Photoshop CS2. To reduce background, brightness and contrast levels were adjusted when necessary. Brightness and contrast levels for controls were also adjusted in parallel under the same parameters.
2.3. Flow Cytometry
FACS was conducted as previously described but adjusted for smaller volumes to accommodate digesting whole hearts [17, 18]. For this hearts were excised, cleaned of any visible clots, washed in PBS and minced into ≤3mm pieces. Minced individual hearts were then digested in 3ml PBS containing a final concentration of 2 mM CaCl2, 1.2units/ml Dispase II and 2 mg/ml Collagenase type IV (both from Worthington, Lakewood, NJ), for 45 minutes at 37°C. Every 15 minutes of the digestion, the tissue was triturated with a 1000μl pipette. Following 45 minutes of incubation, 4ml of HAM’S/F10 supplemented with 15% horse serum (Thermo/HyClone, Logan, UT) was added to each sample to inhibit the digestion. Samples were then passed through a 40μm cell strainer and then centrifuged at 300g rcf for 5 minutes. Following centrifugation, cells were resuspended in hemolysis buffer: 155 mM NH4Cl, 10 mM KHCO3 and 0.1 mM EDTA in H2O. Following 5 minutes of hemolysis at room temperature, cells were centrifuged (300g rcf for 5 min) and washed in PBS+0.3% BSA to remove hemolysis buffer. Cells were centrifuged again to remover residual hemolytic buffer, and once more resuspended in PBS+0.3%, at 100μl per 106 cells. Prior to the addition of antibodies, cells were incubated with 1μg per 106 cells Fc receptor blocking antibody (purified anti-CD16/32) for 10 minutes on ice. We then added any biotin conjugated antibodies for 1 hour on ice, washed, and resuspended in PBS+0.3% containing a cocktail of antibodies and streptavidin that were directly conjugated to fluorophores. Cells were once more incubated on ice for 1 hour, washed and resuspended in PBS+0.3% at 500μl per 106 cells for analysis and sorting. We conducted all FACS acquisition and sorting with an Aria II (BD, San Jose, CA) with Diva software. Unstained and single color controls were used for compensation, which was automatically calculated by the Diva software. For analysis of GFP+ cells, hearts from GFP negative littermate were processed in parallel and used for the compensation controls. For RNA isolation, cells were directly sorted into 1.5ml eppendorf tubes containing 350μl RLT buffer (Qiagen, Valencia, CA), and placed on dry ice immediately following each sort. Antibody specifics (Supplement Table. S2–3) and combinations used (Supplement Table. S4) are listed below.
2.4. Cytocentrifuged Cells
Cells from RGS5lacZ/+ reporter mice were FACS-sorted into DMEM with 10%FCS and immediately cytocentrifuged onto slides (Fisherbrand Super Frost Plus slides) at 800g rcf for 5 minutes. Slides were then fixed with 2% formaldehyde with 0.2% glutaraldehyde for 10 minutes, washed with PBS three times, and incubated with X-gal at 37°C overnight [19]. Following removal of the X-gal staining buffer, slides were washed and stained with eosin Y for 30 seconds, washed with water, and then dried for mounting.
2.5. Bone Marrow Chimeras
Generation of bone marrow chimeras was done as previously described [17]. Briefly, recipients were irradiated with two doses of 0.6Gy, 4 hours apart. Following the second dose of irradiation, we waited an additional 4 hours and then injected donor bone marrow cells via tail vein. Donor bone marrow cells were isolated from femurs of 4 month old female heterozygous for the chicken β-actin promoter driven EGFP allele [20]. Recipients were C57BL/6J males, 12.5 months old at the time of irradiation transplant. Recipients were euthanized and analyzed for bone marrow contribution 11 weeks post-transplant. Femur and tibia bone marrow cells were also analyzed for GFP to verify a sufficient degree of chimerism. Bone marrow chimerism of donor GFP cells was ≥90% relative to controls; bone marrow cells from a C57BL/6J mouse and from a chicken β-actin promoter driven EGFP mouse, both isolated and analyzed as negative and positive control in parallel to chimeras.
2.6. Quantitative-Reverse Transcription PCR
Freshly FACS-sorted cells were extracted for total RNA by using the RNeasy Mini Kit (Qiagen) according to the manufacturer’s protocol. RNA quantity and purity was determined by 260/280 nm absorbance. First-strand cDNA was synthesized by using the High Capacity cDNA synthesis kit with a randomized primer (Applied Biosystems, Foster City, CA) following the manufacturer’s protocol. qRT-PCR reactions using cDNA (20ng) were done as previously described using an ABI 7900HT PCR system, SYBRGreen/Rox PCR master mix (Fermentas, Glen Burnie, MD) for all reactions, and S.D.S software for analysis of comparative Ct method by the formula; 2−ΔCt, where ΔCt = Ct target − Ct 18S rRNA [19]. For Fig. 3 we utilized 2−ΔΔCt = Ct target − Ct 18S rRNA sorted cells− Ct 18S rRNA unsorted cell, to compare samples within each group but not across groups (wt and mdx). All sample reactions were run in triplicate and normalized to 18S rRNA. Ct values derived from each cell type and sample (e.g. each wt and mdx cell population was normalized to its own respective value for 18S) or to 18S of whole wt or mdx hearts respectively (Supplementary Fig. 7–8) to compare samples between wt and mdx groups. Error bars represent the standard error of mean calculated from three independent experiments. Primer sequences for Ctgf, Tgfβ1, Mmp-2, Mmp-9 and 18S were previously reported by Au.CG. et al (2011) [13]. Primers for Collagen1α1, Collagen3α1 and β-actin were previously reported by Kenyon NJ. et al. (2003) [21]. Tgfβr1 primers were reported by Zhou L. et al (2006) [22]. Primers for Sca1 were developed by Primer Bank [23] [24, 25], while primers for αSMA and SM22α have been previously reported by Grabski A. et al (2009)[26]. Primers for Collagen1α2 were reported by Onofre-Oliveira PC. et al (2012)[27]. GAPDH was previously reported by Ieronimakis N. et al (2008)[18]. Specific primer sequences are listed in supplement table S5. Average Ct values generated and used for analysis of Supplementary Fig. 7–8, for comparison of wt and mdx FACS-sorted populations are listed in the supplement table S6.
2.7. Statistical Analysis
P values were derived by two-tailed Student’s t-test. Errors bars represent the standard error of the mean (SEM). Graphs and statistical calculations were generated using Microsoft Excel.
2.8 In vitro Culture and Experiments
Utilizing the aforementioned methods, GFP+ and GFP−, Sca1+, CD31−, CD45− cells were FACS-sorted from 4 month old wt:Col1α1-GFP hearts (n=3 GFP+ mice) and cultured in DMEM-HG with 10% FCS at 37°C, 5%CO2 and 5%O2. Both GFP+ and GFP− cells were maintained in culture and examined for the presence of GFP for 30 days. At this time GFP+ cells were pooled and expanded into two twelve well plates and grown to confluency for treatment with TGFβ1. For fibrogenic induction, 4 wells from each plate were treated with one of the following with DMEM-HG + 5% FCS as the basal media; 1) DMSO vehicle control, 2) TGFβ1 at a final concentration of 10ng/ml, 3) 10ng/ml TGFβ1 with 1μM of the TGFβR1 inhibitor (SB525334) [16]. Following 4 days of treatment, cells for collagen staining were fixed with 4% formaldehyde for 30 minutes then stained with picrosirius red for 1hour. Quantification of collagen by picrosirius red staining was done as percentage of area stained within individual fields as depicted in Fig. 6B, and normalized to the area measured using ImageJ v1.40. Cells collected for gene expression analysis were scraped and suspended in RLT lysis buffer (350μl per well of a 12 well plate) for RNA isolation, cDNA synthesis, and PCR analysis using the same reagents and methods/conditions outlined in section 2.6. Cells from wt:PDGFRα-GFP and wt:Sca1-GFP mice depicted in Supplemental Fig. 20–21, were also sorted and cultured under the same aforementioned conditions.
3. Results
3.1. Coronary adventitial cells extend to occupy perivascular fibrosis and are distinct from pericytes and inflammatory cells
Sca1 is a surface receptor associated with many cell types including macrovascular adventitial cells [28–30]. We initially examined wild-type (wt) hearts and observed that in addition to endothelial cells, coronary adventitial cells were also Sca1+. Utilizing the Sca1-GFP transgenic reporter mouse, we confirmed expression and co-localization of Sca1 to the coronary adventitia [31]. To distinguish the vascular endothelium which also expresses Sca1 in this model [18, 32–35], we intravenously (IV) injected the lectin wheat germ agglutinin (WGA) prior to euthanasia to label the vasculature. Histological survey of cross-sections from these hearts revealed Sca1-GFP + cells negative for IV injected-WGA, localized to the coronary adventitia (Fig. 1A) and distinguishable from endothelial cells (Sca1-GFP+ and positive for IV injected-WGA) and pericytes (NG2+, Sca1-GFP −) (Fig. 1B). Further characterization of Sca1+ coronary adventitial cells was performed in sections from mdx hearts by co-localization with picrosirius red, a dye that stains collagen and is routinely used for identifying fibrosis [36]. Sca1+ cells in mdx hearts were abundant within the coronary adventitia and distinguishable from BS1+ endothelial cells which also express Sca1 (Fig. 1C) [37]. Consistently, we observed Sca1+ cells extending from the coronary adventitia to proximal regions of severe perivascular fibrosis (Fig. 2 and Supplement Fig. 1). In older mdx hearts, Sca1+ cells occupied sizable regions of fibrosis throughout the myocardium (Supplement Fig. 2). This population of Sca1+ adventitial cells surrounding coronary arteries was also negative for CD31, expressed by endothelial and inflammatory cells, and CD45, a marker of hematopoietic cells (Supplement Fig. 3) [38, 39]. In concordance with our previously published work, we observed Sca1+, CD45+ inflammatory cells which were present in damaged regions of mdx hearts (Supplement Fig. 3C)[17]. However, analysis of bone marrow chimeras indicated that Sca1+ adventitial cells are not bone marrow-derived (Supplement Fig. 4). Moreover, we observed these cells were negative for Thy1, a receptor associated with cardiac fibroblasts, and Rgs5lacZ, a reporter expressed by pericytes and smooth muscle cells (Supplement Fig. 5) [40, 41].
3.2. Molecular analysis reveals coronary adventitial cells express pro-fibrotic genes
To further characterize the Sca1+ coronary adventitial cells, we FACS-sorted the same population identified as Sca1+, CD31−, CD45− by histology, for gene expression analysis (Fig. 3A). For FACS-analysis and sorting, whole hearts were digested with collagenase and neutral protease, enzymes commonly used to produce single cell suspensions and retain cell surface antigens [19, 42–44]. FACS-analysis revealed that the majority of Sca1+, CD31−, CD45− cells are positive for PDGFRα and CD34 (Fig. 3B). PDGFRα signaling has been implicated in the formation of fibrosis and is expressed by fibrotic cells of the skeletal muscle [45], [46]. Conversely, CD34 is expressed by many cell types, including progenitor cells of the macrovascular adventitia [29]. In contrast, the Sca1+, CD31−, CD45− population was negative for CD133, a marker of circulating progenitors, and expressed only low levels of the fibroblast marker Thy1.2 (the C57BL/6 strain allele for Thy1) [47]. To compare the abundance Sca1+, CD31−, CD45− cells between wt and mdx, we calculated the number of cells per mg tissue by multiplying the proportion generated by FACS to number of cells counted following digestion over the initial weight of each heart [48]. In turn, the number of Sca1+, CD31−, CD45− cells was two-fold greater in mdx vs. wt hearts (Fig. 3C). Furthermore, the proportion of Sca1+ cells among the PDGFRα +, CD31−, CD45− population significantly increased in mdx hearts (Fig. 3C).
To survey the expression of genes implicated in fibrotic tissue formation, we FACS-sorted the Sca1+, CD31−, CD45− adventitial population directly into lysis/RNA isolation buffer for quantitative reverse-transcription PCR (qRT-PCR) analysis. In parallel we also sorted endothelial cells (Sca1+, CD31+, CD45−), interstitial fibroblasts (Sca1−, PDFGRα+, CD31−, CD45−) and macrophages (F4/80+, CD45+) which have been reported to mediate fibrosis via the TGFβ pathway [18, 45, 46, 49, 50]. For this comparison, we could only sort sufficient numbers of macrophages from mdx but not wt hearts. Results indicate that adventitial cells (Sca1+, CD31−, CD45− cells) and Sca1−, PDFGRα+, CD31−, CD45− cells express similar levels of Collagen1α1 and Collagen3α1 (Fig. 3D left graph) and Ctgf, Tgfrβr1, and Tgfβ1 mRNA in wt hearts (Fig. 3E left graph). In contrast, Sca1+ adventitial cells isolated from mdx hearts expressed significantly greater levels of all these genes as compared to Sca1−, PDFGRα+, CD31−, CD45− cells isolated from the same mdx hearts (Fig. 3D right graph and 3E right graph). As previously reported for mdx whole heart tissue, the expression of Collagen3α1 was also greater than Collagen1α1 in mdx cells [13]. Of note, type III collagen is a fibrillar collagen essential for vessel stability and is produced at greater levels than type I collagen by pro-fibrotic aortic adventitial cells [51, 52]. We also observed elevated expression of these pro-collagens in the right vs. left ventricles of 12 month old mdx mice (Supplementary Fig. 6), which have been shown to develop right ventricle dysfunction prior to left ventricle dysfunction [53, 54]. Surprisingly, relative to the other populations analyzed from mdx hearts, endothelial cells expressed the greatest level of the Tgfβ1 ligand (Fig. 3E right graph). The expression of the majority of pro-fibrotic genes depicted in Fig. 3, was greater in mdx sorted cells for each respective population. A more comprehensive analysis indicates that the expression of these genes, with the exception of endothelial cell Ctgf expression, is elevated in mdx vs. wt sorted cells (supplement Fig. 7–8).
Immunostaining for the TGFβ1 ligand confirmed co-localization with microvascular endothelial cells around damaged regions of mdx hearts (Supplemental Fig. 9). Staining for TGFβ1 ligand was also observed in Sca1+ endothelial and adventitial cells of mdx coronary arteries (Supplemental Fig. 10). Staining for TGFβR1 was more diffuse and localized with most of the vasculature including adventitial and vascular smooth muscle cells. In contrast, TGFβR2 which mediates TGFβ signaling via phosphorylation of TGFβR1, co-localized with Sca1+ adventitial cells and endothelial cells lining the coronary arteries (Supplementary Fig. 11–12), [55, 56]. In addition to TGFβ1, endothelial cells expressed high levels of Mmp-9, while Sca1+ adventitial cells expressed the greatest level of Mmp-2 (Supplement Fig. 13); both of these MMPs covert latent TGFβ ligands to active forms [57]. Altogether, this gene expression profile and presence of TGFβ1 ligand and TGFβ receptors in the adventitia of mdx coronary arteries, indicates that Sca1+ adventitial cells respond to TGFβ1 and are pro-fibrotic in mdx hearts. These findings implicate the endothelium in promoting fibrosis via the TGFβ1 signaling pathway in response to chronic disease present in mdx hearts.
3.3. The majority of coronary adventitial cells express Collagen1α1 and are distinguishable from interstitial fibroblasts by their expression of Sca1
Although these results suggest that Sca1+ adventitial cells contribute to perivascular fibrosis, the heterogeneity of fibrotic cells within this population remained unclear. Therefore, we utilized the Collagen1α1-GFP (Col1α1-GFP) reporter mice to analyze the proportion of fibrotic cells within this population [58]. Type I collagen is abundant in cardiac fibrosis and thus GFP expression in this model is indicative of fibrotic cells [58, 59]. For this we generated mdx:Col1α1-GFP mice and compared them to age matched wt:Col1α1-GFP animals (n=3 wt, n=3 mdx; 4 months old, all males) (Fig. 4 and Supplement Fig. 14). By FACS-analysis, the majority of Sca1+, CD31−, CD45− adventitial cells were GFP+ in both of wt (71% ±4.1) and mdx (77% ±3.5) hearts (Fig. 4A and Supplement Fig. 14A). In agreement with our qRT-PCR results (Fig. 3D), we detected GFP+ cells within the PDGFRα+, Sca1−, CD31−, CD45− population; 69% ±4.8 in wt and 47% ±12.9 in mdx, were GFP+ within this population (P=0.19 between wt vs. mdx). In contrast, we did not detect GFP+ cells within the hematopoietic (CD45+) or endothelial (CD31+, Sca1+, CD45−) cell populations from either wt or mdx hearts. Histological analysis of mdx:Col1α1-GFP hearts confirmed the anatomical position of Sca1+, PDGFRα+, GFP+ cells to the coronary adventitia and the presence of Sca1−, PDGFRα+, GFP+ in the interstitium (Fig. 4B–D). Sca1+, Col1α1-GFP+ cells also co-localized with staining for collagen1 and fibronectin, in the adventitial space of coronary vessels of mdx hearts (Supplementary Fig. 15). Both collagen type I and fibronectin are extracellular matrix proteins abundant in fibrotic tissue and are directly regulated by TGFβ1 signaling [60] [61]. By FACS analysis the majority of cells expressing Col1α1-GFP were positive for PDGFRα+ in both wt (89% ±1.3) and mdx (97% ±0.9) hearts (Supplement Fig. 8B). Further characterization showed that cardiac Sca1+, Col1α1-GFP+ cells were negative, while a minority of Sca1+, Col1α1-GFP− cells were positive (<5%) for c-Kit (Supplementary Fig. 16A); a marker associated with cardiac progenitors [62]. In addition, we confirmed the lack of Sca1 expression in Sca1−, PDGFRα+, Col1α1-GFP+ sorted cells by qRT-PCR (Supplementary Fig. 16B).
Pericytes that express Collagen1α1-GFP have been reported to be fibrotic in the kidney [58]. However, Sca1+ adventitial cells identified by their position surrounding coronary smooth muscle and absence of NG2 staining (Fig. 1B), fall outside the anatomical and phenotypic definition of pericytes (Fig. 1B). In turn, the Col1α1-GFP+, Sca1− cells observed in the interstitial space were also negative for NG2 (Fig. 5). Utilizing the PDGFRα-GFP reporter mouse, we confirmed that coronary adventitial and non-pericyte (NG2 negative) interstitial cells express PDGFRα (Supplementary Fig. 17). Interestingly, PDGFRα expressing cells were also abundant in the macrovascular adventitia (Supplementary Fig. 18), which has been previously reported to express Sca1 [30]. These data suggest that additional collagen1 producing cells, including interstitial fibroblasts, are PDGFRα+ and distinguishable from pericytes; however, these cells are also distinguishable from adventitial cells by the absence of Sca1 expression.
3.4. Coronary adventitial derived cells become fibrotic via TGFβ1 signaling in vitro
To characterize the molecular mechanism of fibrosis, we FACS-sorted and cultured for in vitro study, adventitial cells (Sca1+, CD31−, CD45−) that were GFP+ (majority) and GFP− (minority) from wt:Col1α1-GFP hearts (n=3). In culture Sca1+, CD31−, CD45− sorted as GFP+ maintained Col1α1-GFP transgene expression, whereas Sca1+, CD31−, CD45− sorted as GFP− never expressed GFP within the 4 week time frame surveyed (Fig. 6A). In contrast, Sca1−, PDGFRα+, CD31−, CD45− cells sorted as GFP+ maintained Col1α1-GFP expression (Supplementary Fig. 12). Interestingly both Sca1+/−, GFP+ sorted populations that maintained Col1α1-GFP expression, gave rise to cells in culture with a smooth muscle like phenotype; positive for αSMA but negative for Sca1 (Supplementary Fig. 19). The apparent loss of Sca1 expression by Sca1+ sorted cells occurred early in culture, while Sca1−, PDGFRα+ sorted cells remained negative for Sca1 expression during the same time-course examined for both populations (Supplementary Fig. 20A). Within this same period, PDGFRα expression was maintained by both populations (Supplementary Fig. 20B). Interestingly, the expression of αSMA also occurred early in culture, as cells derived from both Sca1+ and Sca1− sorted populations stained positive at 36 hours in culture, and showed pronounced αSMA staining by day 7 in culture (Supplementary Fig. 21).
Despite being able to observe cells derived from both Sca1+ and Sca1− sorted populations early in culture, only cells derived from the Sca1+, CD31−, CD45− sorted population, were able to expand sufficiently for in vitro study. Under the given culture conditions, we were not able to sufficiently expand cells derived from both Sca1+, Col1α1-GFP−, CD31−, CD45− or Sca1−, PDGFRα+, Col1α1-GFP+, CD31−, CD45− sorted populations, for in vitro comparison with Sca1+, Col1α1-GFP+ derived cells. Therefore, we could only assess the response of cultured cells derived from Sca1+ Col1α1-GFP+ sorted cells (which maintained Col1-GFP expression), to TGFβ1 in order to gain insight on the role of pro-fibrotic signaling in adventitial cell mediated fibrosis.
For this assay, cultured cells were treated in parallel with the vehicle, 10ng/ml TGFβ1, or 10ng/ml TGFβ1 with 1μM SB525334, a potent inhibitor of TGFβR1 kinase activity that has been shown to reduce collagen production both in vitro and in vivo [16, 63]. All three treatments were tested in quadruplicate, two times; once for morphological analysis of collagen production with picrosirius red staining (Fig. 6B), and secondly for molecular analysis of pro-fibrotic gene expression by qRT-PCR (Fig. 6C). Results from both visual and molecular analyses’ indicate that TGFβ1 stimulates adventitial derived cells to become fibrotic. Expression levels for Collagens1α1, 1α2, and 3α1 increased dramatically with the addition of TGFβ1. In contrast to freshly sorted cells which expressed elevated levels of Collagen3α1 (Fig. 3D), cultured adventitial cells expressed greater levels of type I pro-collagens in response to TGFβ1. TGFβ1 is known to stimulate the expression of both type I pro-collagens via Smad3 [64] [65, 66]. In contrast, the regulation of Collagen3α1 expression is less understood and may require additional factors present in vivo that synergistically promote the production collagen type III over type I. Interestingly, exposure to TGFβ1 also increased expression of Tgfβ1 and Tgfβr1, suggesting that an autocrine response may sustain the fibrotic response of activated adventitial cells. In contrast, inhibition of TGFβR1 signaling by SB525334, reduced picrosirius red staining and resulted in even lower expression of Collagen1α1, 1α2 and 3α1 vs. vehicle control treated cells. Consequently, SB525334 treated cells showed reduced expression of Tgfβ1 and Tgfβr1, suggesting that pharmacological inhibition of TGFβR1 kinase activity results in a feedback response that may decrease the fibrotic response of adventitial cells to TGFβ1.
In addition to our survey of pro-fibrotic genes, we examined the expression of smooth muscle associated genes, as we observed cultured cells stained positive for αSMA+ (Supplementary Fig. 19 and 21) and it has been reported that cells derived from the macrovascular adventitia can give rise to smooth muscle like cells in vitro [29, 30, 67]. qRT-PCR analysis of freshly sorted Sca1+, Col1α1-GFP +, CD31−, CD45− cells (Supplementary Fig. 22A), indicates that in vivo coronary adventitial cells express almost undetectable levels of αSMA and SM22α;genes expressed by developing and mature smooth muscle cells [68–70]. In contrast, cells derived from this Sca1+, Col1α1-GFP+, CD31−, CD45− sorted population in culture, express αSMA and low levels of SM22α (Supplementary Fig. 22B). Treatment with TGFβ1, which results in upregulation of Collagen1α1, 1α2 and 3α1, and increased collagen deposition (Fig. 6), also significantly reduced the expression of these smooth muscle associated genes (Supplementary Fig. 22B). Therefore, it is possible that coronary adventitial cells can give rise to smooth muscle-like cells that can convert to a fibroblast phenotype in response to pro-fibrotic stimuli. However, without rigorous lineage tracing studies, we take caution in suggesting that this process occurs in vivo and is not exclusive to cell culture.
4. Discussion
Fibrosis is a primary indicator of disease progression in DMD [71]. Late gadolinium enhancement can detect fibrosis in the heart of DMD patients and corresponds with decreased ejection fraction and unfavorable left ventricle remodeling [72]. Progressive fibrosis has also been shown to perturb the hemodynamics of mdx hearts even following dystrophin rescue by AAV mediated gene therapy [54, 73]. Therefore, elucidating the molecular mechanisms and cellular processes that govern fibrosis, is critical for preventing or reversing cardiac dysfunction in muscular dystrophy.
Herein this report, we implicate coronary adventitial cells as the cell population associated with perivascular fibrosis. We have characterized these cells using a host of markers in relation to the anatomical position of the coronary adventitia. Interestingly, adventitial cells and interstitial fibroblasts expressed similar markers, but were distinguishable by the expression of Sca1. Numerous studies have reported that cardiac progenitor and/or stem cells also express Sca1 [74−76]. In turn, we did observe a minority of Sca1+, CD31−, CD45− cells were positive for c-Kit and did no express Col1α1-GFP in vivo or in vitro. In contrast, Sca1+, Col1α1-GFP+ adventitial cells gave rise to Sca1− cells that maintained PDGFRα expression and began expressing smooth muscle associated genes in culture. Therefore, it is possible that Sca1+ coronary adventitial cells or a subset of progenitor within this population is capable of giving rise to smooth muscle like cells and/or Sca1−, PDGFRα+ interstitial fibroblasts. Indeed, Hu et al., showed that Sca1+ cells from the aortic adventitia can contribute to smooth muscle like cells in the atherosclerotic lesion of ApoE null mice [29]. Given the close proximity of coronary adventitial cells to coronary endothelium, it is also possible that pro-fibrotic adventitial cells emerge via endothelial-to-mesenchymal transition [77], as both cell types share expression of Sca1 and Tgfβ1. However, the focus of this report was to gain insight into the natural role of adventitial cells in cardiac fibrosis. Furthermore, without proper lineage tracing (e.g. lack of commercially available, inducible Sca1-Cre models) the relationship between putative Sca1+ stem cells and pro-fibrotic adventitial cells will remain enigmatic but warrants future investigation.
In retrospect, adventitial cells from wt hearts express genes characteristic of cardiac extracellular matrix including the Col1α1-GFP reporter, but were distinct from NG2+ pericytes that did not express the Col1α1-GFP transgene in the heart. In mdx hearts, we not only observe adventitial cells occupying regions of perivascular fibrosis, but the expression of fibrosis-related genes is elevated in comparison to wt hearts. Specifically, elevated expression of Tgfβr1 by mdx adventitial cells implicated TGFβ1 signaling pathway as a potential molecular mechanism of perivascular fibrosis. Indeed, in vitro treatment of adventitial cells with TGFβ1 resulted in elevated collagen production suggesting TGFβ1 signaling may be implicated in mdx perivascular fibrosis. Accordingly, inhibition of TGFβ signaling has been shown to reduce fibrosis and improve skeletal muscle and cardiac function of mdx mice [78–81]. Importantly, we observed elevated expression of the Tgfβ1 ligand in mdx derived coronary endothelial cells. These data suggest that the endothelium may play a role in the signaling of perivascular fibrosis in chronic disease (proposed model; Fig. 6D). Response to sheer stress has been reported to upregulate Tgfβ1 expression in endothelial cells [82]. Incidentally, shear stress-induced endothelial vasodilation is reduced in mdx arteries [83]. Therefore, alterations in shear stress response and/or pressure overload in the vessel wall may trigger cardiac perivascular fibrosis in DMD and other chronic diseases [84, 85].
In summary, our findings provide new insights into the cellular interactions and signaling pathways responsible for perivascular fibrosis and identify the coronary adventitia as a novel target for development of anti-fibrotic therapies.
Supplementary Material
Highlights.
Adventitial cells extend appear to occupy perivascular fibrosis in mdx hearts.
In mdx hearts Adventitial cells express elevated levels of pro-fibrotic genes.
Endothelial cells derived from mdx hearts express elevated levels TGFβ1 ligand.
The majority of adventitial cells express Col1α1-GFP, a reporter of fibrotic cells.
Adventitial cells give rise to pro-fibrotic cells in response to TGFβ1 in vitro.
Acknowledgments
We thank Dr. Renee LeBoeuf and Frank Dastvan for providing the Sca1 qPCR primers and carotid artery cDNA.
Sources of Funding
This work was supported by the American Heart Association award 11BGIA7140028 to M.R. The Seattle Children’s Research Institute and NIH RO1 HL-093594 to M.W.M. NIH grants HL087513 and HL094374 to W.M.M. The UW Nathan Shock Center of Excellence in the Basic Biology of Aging Genetic Approaches to Aging Training grant T32 AG000057 and Pancretan Association of America Venizelion Scholarship to N.I. And the Anandamahidol Foundation Scholarship of Thailand to K.J.
Footnotes
Disclosure Statement
The authors concede no conflicts of interest in the publication of this manuscript.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Deconinck N, Dan B. Pathophysiology of duchenne muscular dystrophy: current hypotheses. Pediatric neurology. 2007;36:1–7. doi: 10.1016/j.pediatrneurol.2006.09.016. [DOI] [PubMed] [Google Scholar]
- 2.Culligan KG, Mackey AJ, Finn DM, Maguire PB, Ohlendieck K. Role of dystrophin isoforms and associated proteins in muscular dystrophy (review) International journal of molecular medicine. 1998;2:639–48. doi: 10.3892/ijmm.2.6.639. [DOI] [PubMed] [Google Scholar]
- 3.Sultan A, Fayaz M. Prevalence of cardiomyopathy in Duchenne and Becker’s muscular dystrophy. J Ayub Med Coll Abbottabad. 2008;20:7–13. [PubMed] [Google Scholar]
- 4.Spurney CF. Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions. Muscle & nerve. 2011;44:8–19. doi: 10.1002/mus.22097. [DOI] [PubMed] [Google Scholar]
- 5.Eagle M, Baudouin SV, Chandler C, Giddings DR, Bullock R, Bushby K. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord. 2002;12:926–9. doi: 10.1016/s0960-8966(02)00140-2. [DOI] [PubMed] [Google Scholar]
- 6.Frankel KA, Rosser RJ. The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis. Human pathology. 1976;7:375–86. doi: 10.1016/s0046-8177(76)80053-6. [DOI] [PubMed] [Google Scholar]
- 7.Moriuchi T, Kagawa N, Mukoyama M, Hizawa K. Autopsy analyses of the muscular dystrophies. The Tokushima journal of experimental medicine. 1993;40:83–93. [PubMed] [Google Scholar]
- 8.Naruse H, Miyagi J, Arii T, Ohyanagi M, Iwasaki T, Jinnai K. The relationship between clinical stage, prognosis and myocardial damage in patients with Duchenne-type muscular dystrophy: five-year follow-up study. Annals of nuclear medicine. 2004;18:203–8. doi: 10.1007/BF02985001. [DOI] [PubMed] [Google Scholar]
- 9.Weisenfeld S, Messinger WJ. Cardiac involvement in progressive muscular dystrophy. American heart journal. 1952;43:170–87. doi: 10.1016/0002-8703(52)90209-3. [DOI] [PubMed] [Google Scholar]
- 10.Dai Z, Aoki T, Fukumoto Y, Shimokawa H. Coronary perivascular fibrosis is associated with impairment of coronary blood flow in patients with non-ischemic heart failure. Journal of cardiology. 2012 doi: 10.1016/j.jjcc.2012.06.009. [DOI] [PubMed] [Google Scholar]
- 11.Zhou L, Lu H. Targeting fibrosis in Duchenne muscular dystrophy. Journal of neuropathology and experimental neurology. 2010;69:771–6. doi: 10.1097/NEN.0b013e3181e9a34b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Quinlan JG, Hahn HS, Wong BL, Lorenz JN, Wenisch AS, Levin LS. Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings. Neuromuscul Disord. 2004;14:491–6. doi: 10.1016/j.nmd.2004.04.007. [DOI] [PubMed] [Google Scholar]
- 13.Au CG, Butler TL, Sherwood MC, Egan JR, North KN, Winlaw DS. Increased connective tissue growth factor associated with cardiac fibrosis in the mdx mouse model of dystrophic cardiomyopathy. International journal of experimental pathology. 2010;92:57–65. doi: 10.1111/j.1365-2613.2010.00750.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Sun G, Haginoya K, Wu Y, Chiba Y, Nakanishi T, Onuma A, et al. Connective tissue growth factor is overexpressed in muscles of human muscular dystrophy. Journal of the neurological sciences. 2008;267:48–56. doi: 10.1016/j.jns.2007.09.043. [DOI] [PubMed] [Google Scholar]
- 15.Lijnen PJ, Petrov VV, Fagard RH. Induction of cardiac fibrosis by transforming growth factor-beta(1) Molecular genetics and metabolism. 2000;71:418–35. doi: 10.1006/mgme.2000.3032. [DOI] [PubMed] [Google Scholar]
- 16.Grygielko ET, Martin WM, Tweed C, Thornton P, Harling J, Brooks DP, et al. Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type I receptor kinase in puromycin-induced nephritis. The Journal of pharmacology and experimental therapeutics. 2005;313:943–51. doi: 10.1124/jpet.104.082099. [DOI] [PubMed] [Google Scholar]
- 17.Ieronimakis N, Hays A, Reyes M. Bone marrow-derived cells do not engraft into skeletal muscle microvasculature but promote angiogenesis after acute injury. Experimental hematology. 2012;40:238–49. e3. doi: 10.1016/j.exphem.2011.12.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Ieronimakis N, Balasundaram G, Reyes M. Direct isolation, culture and transplant of mouse skeletal muscle derived endothelial cells with angiogenic potential. PloS one. 2008;3:e0001753. doi: 10.1371/journal.pone.0001753. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Ieronimakis N, Balasundaram G, Rainey S, Srirangam K, Yablonka-Reuveni Z, Reyes M. Absence of CD34 on murine skeletal muscle satellite cells marks a reversible state of activation during acute injury. PloS one. 2008;5:e10920. doi: 10.1371/journal.pone.0010920. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. ‘Green mice’ as a source of ubiquitous green cells. FEBS letters. 1997;407:313–9. doi: 10.1016/s0014-5793(97)00313-x. [DOI] [PubMed] [Google Scholar]
- 21.Kenyon NJ, Ward RW, McGrew G, Last JA. TGF-beta1 causes airway fibrosis and increased collagen I and III mRNA in mice. Thorax. 2003;58:772–7. doi: 10.1136/thorax.58.9.772. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Zhou L, Porter JD, Cheng G, Gong B, Hatala DA, Merriam AP, et al. Temporal and spatial mRNA expression patterns of TGF-beta1, 2, 3 and TbetaRI, II, III in skeletal muscles of mdx mice. Neuromuscul Disord. 2006;16:32–8. doi: 10.1016/j.nmd.2005.09.009. [DOI] [PubMed] [Google Scholar]
- 23.Wang X, Seed B. A PCR primer bank for quantitative gene expression analysis. Nucleic acids research. 2003;31:e154. doi: 10.1093/nar/gng154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Spandidos A, Wang X, Wang H, Dragnev S, Thurber T, Seed B. A comprehensive collection of experimentally validated primers for Polymerase Chain Reaction quantitation of murine transcript abundance. BMC genomics. 2008;9:633. doi: 10.1186/1471-2164-9-633. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Spandidos A, Wang X, Wang H, Seed B. PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic acids research. 2010;38:D792–9. doi: 10.1093/nar/gkp1005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Grabski AD, Shimizu T, Deou J, Mahoney WM, Jr, Reidy MA, Daum G. Sphingosine-1-phosphate receptor-2 regulates expression of smooth muscle alpha-actin after arterial injury. Arteriosclerosis, thrombosis, and vascular biology. 2009;29:1644–50. doi: 10.1161/ATVBAHA.109.191965. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Onofre-Oliveira PC, Santos AL, Martins PM, Ayub-Guerrieri D, Vainzof M. Differential expression of genes involved in the degeneration and regeneration pathways in mouse models for muscular dystrophies. Neuromolecular medicine. 2012;14:74–83. doi: 10.1007/s12017-012-8172-3. [DOI] [PubMed] [Google Scholar]
- 28.Holmes C, Stanford WL. Concise review: stem cell antigen-1: expression, function, and enigma. Stem cells (Dayton, Ohio) 2007;25:1339–47. doi: 10.1634/stemcells.2006-0644. [DOI] [PubMed] [Google Scholar]
- 29.Hu Y, Zhang Z, Torsney E, Afzal AR, Davison F, Metzler B, et al. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. The Journal of clinical investigation. 2004;113:1258–65. doi: 10.1172/JCI19628. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Passman JN, Dong XR, Wu SP, Maguire CT, Hogan KA, Bautch VL, et al. A sonic hedgehog signaling domain in the arterial adventitia supports resident Sca1+ smooth muscle progenitor cells. Proceedings of the National Academy of Sciences of the United States of America. 2008;105:9349–54. doi: 10.1073/pnas.0711382105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Ma X, Robin C, Ottersbach K, Dzierzak E. The Ly-6A (Sca-1) GFP transgene is expressed in all adult mouse hematopoietic stem cells. Stem cells (Dayton, Ohio) 2002;20:514–21. doi: 10.1634/stemcells.20-6-514. [DOI] [PubMed] [Google Scholar]
- 32.Kotton DN, Summer RS, Sun X, Ma BY, Fine A. Stem cell antigen-1 expression in the pulmonary vascular endothelium. American journal of physiology. 2003;284:L990–6. doi: 10.1152/ajplung.00415.2002. [DOI] [PubMed] [Google Scholar]
- 33.Stuelsatz P, Keire P, Almuly R, Yablonka-Reuveni Z. A contemporary atlas of the mouse diaphragm: myogenicity, vascularity, and the Pax3 connection. The journal of histochemistry and cytochemistry: official journal of the Histochemistry Society. 2012;60:638–57. doi: 10.1369/0022155412452417. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Kirillova I, Gussoni E, Goldhamer DJ, Yablonka-Reuveni Z. Myogenic reprogramming of retina-derived cells following their spontaneous fusion with myotubes. Developmental biology. 2007;311:449–63. doi: 10.1016/j.ydbio.2007.08.056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Day K, Paterson B, Yablonka-Reuveni Z. A distinct profile of myogenic regulatory factor detection within Pax7+ cells at S phase supports a unique role of Myf5 during posthatch chicken myogenesis. Developmental dynamics: an official publication of the American Association of Anatomists. 2009;238:1001–9. doi: 10.1002/dvdy.21903. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Whittaker P, Kloner RA, Boughner DR, Pickering JG. Quantitative assessment of myocardial collagen with picrosirius red staining and circularly polarized light. Basic research in cardiology. 1994;89:397–410. doi: 10.1007/BF00788278. [DOI] [PubMed] [Google Scholar]
- 37.Yeh HI, Dupont E, Coppen S, Rothery S, Severs NJ. Gap junction localization and connexin expression in cytochemically identified endothelial cells of arterial tissue. J Histochem Cytochem. 1997;45:539–50. doi: 10.1177/002215549704500406. [DOI] [PubMed] [Google Scholar]
- 38.Scholz D, Schaper J. Platelet/endothelial cell adhesion molecule-1 (PECAM-1) is localized over the entire plasma membrane of endothelial cells. Cell and tissue research. 1997;290:623–31. doi: 10.1007/s004410050968. [DOI] [PubMed] [Google Scholar]
- 39.Stelzer GT, Shults KE, Loken MR. CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Annals of the New York Academy of Sciences. 1993;677:265–80. doi: 10.1111/j.1749-6632.1993.tb38783.x. [DOI] [PubMed] [Google Scholar]
- 40.Hudon-David F, Bouzeghrane F, Couture P, Thibault G. Thy-1 expression by cardiac fibroblasts: lack of association with myofibroblast contractile markers. Journal of molecular and cellular cardiology. 2007;42:991–1000. doi: 10.1016/j.yjmcc.2007.02.009. [DOI] [PubMed] [Google Scholar]
- 41.Nisancioglu MH, Mahoney WM, Jr, Kimmel DD, Schwartz SM, Betsholtz C, Genove G. Generation and characterization of rgs5 mutant mice. Molecular and cellular biology. 2008;28:2324–31. doi: 10.1128/MCB.01252-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Kuang S, Kuroda K, Le Grand F, Rudnicki MA. Asymmetric self-renewal and commitment of satellite stem cells in muscle. Cell. 2007;129:999–1010. doi: 10.1016/j.cell.2007.03.044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Sacco A, Doyonnas R, Kraft P, Vitorovic S, Blau HM. Self-renewal and expansion of single transplanted muscle stem cells. Nature. 2008;456:502–6. doi: 10.1038/nature07384. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Jackaman C, Nowak KJ, Ravenscroft G, Lim EM, Clement S, Laing NG. Novel application of flow cytometry: determination of muscle fiber types and protein levels in whole murine skeletal muscles and heart. Cell motility and the cytoskeleton. 2007;64:914–25. doi: 10.1002/cm.20239. [DOI] [PubMed] [Google Scholar]
- 45.Uezumi A, Ito T, Morikawa D, Shimizu N, Yoneda T, Segawa M, et al. Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle. Journal of cell science. 124:3654–64. doi: 10.1242/jcs.086629. [DOI] [PubMed] [Google Scholar]
- 46.Olson LE, Soriano P. Increased PDGFRalpha activation disrupts connective tissue development and drives systemic fibrosis. Developmental cell. 2009;16:303–13. doi: 10.1016/j.devcel.2008.12.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Timmermans F, Plum J, Yoder MC, Ingram DA, Vandekerckhove B, Case J. Endothelial progenitor cells: identity defined? Journal of cellular and molecular medicine. 2009;13:87–102. doi: 10.1111/j.1582-4934.2008.00598.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Bonner F, Borg N, Burghoff S, Schrader J. Resident cardiac immune cells and expression of the ectonucleotidase enzymes CD39 and CD73 after ischemic injury. PloS one. 2012;7:e34730. doi: 10.1371/journal.pone.0034730. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Austyn JM, Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. European journal of immunology. 1981;11:805–15. doi: 10.1002/eji.1830111013. [DOI] [PubMed] [Google Scholar]
- 50.Vidal B, Serrano AL, Tjwa M, Suelves M, Ardite E, De Mori R, et al. Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation pathway. Genes & development. 2008;22:1747–52. doi: 10.1101/gad.465908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Liu X, Wu H, Byrne M, Krane S, Jaenisch R. Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proceedings of the National Academy of Sciences of the United States of America. 1997;94:1852–6. doi: 10.1073/pnas.94.5.1852. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Goel SA, Guo LW, Shi XD, Kundi R, Sovinski G, Seedial S, et al. Preferential secretion of collagen type 3 versus type 1 from adventitial fibroblasts stimulated by TGF-beta/Smad3-treated medial smooth muscle cells. Cellular signalling. 2013;25:955–60. doi: 10.1016/j.cellsig.2012.12.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Zhang W, ten Hove M, Schneider JE, Stuckey DJ, Sebag-Montefiore L, Bia BL, et al. Abnormal cardiac morphology, function and energy metabolism in the dystrophic mdx mouse: an MRI and MRS study. Journal of molecular and cellular cardiology. 2008;45:754–60. doi: 10.1016/j.yjmcc.2008.09.125. [DOI] [PubMed] [Google Scholar]
- 54.Stuckey DJ, Carr CA, Camelliti P, Tyler DJ, Davies KE, Clarke K. In vivo MRI characterization of progressive cardiac dysfunction in the mdx mouse model of muscular dystrophy. PloS one. 2012;7:e28569. doi: 10.1371/journal.pone.0028569. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, et al. TGF beta signals through a heteromeric protein kinase receptor complex. Cell. 1992;71:1003–14. doi: 10.1016/0092-8674(92)90395-s. [DOI] [PubMed] [Google Scholar]
- 56.Wrana JL, Attisano L, Wieser R, Ventura F, Massague J. Mechanism of activation of the TGF-beta receptor. Nature. 1994;370:341–7. doi: 10.1038/370341a0. [DOI] [PubMed] [Google Scholar]
- 57.Bujak M, Frangogiannis NG. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovascular research. 2007;74:184–95. doi: 10.1016/j.cardiores.2006.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Lin SL, Kisseleva T, Brenner DA, Duffield JS. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. The American journal of pathology. 2008;173:1617–27. doi: 10.2353/ajpath.2008.080433. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Bishop JE, Greenbaum R, Gibson DG, Yacoub M, Laurent GJ. Enhanced deposition of predominantly type I collagen in myocardial disease. Journal of molecular and cellular cardiology. 1990;22:1157–65. doi: 10.1016/0022-2828(90)90079-h. [DOI] [PubMed] [Google Scholar]
- 60.Villarreal FJ, Dillmann WH. Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen. The American journal of physiology. 1992;262:H1861–6. doi: 10.1152/ajpheart.1992.262.6.H1861. [DOI] [PubMed] [Google Scholar]
- 61.Serini G, Bochaton-Piallat ML, Ropraz P, Geinoz A, Borsi L, Zardi L, et al. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. The Journal of cell biology. 1998;142:873–81. doi: 10.1083/jcb.142.3.873. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003;114:763–76. doi: 10.1016/s0092-8674(03)00687-1. [DOI] [PubMed] [Google Scholar]
- 63.Higashiyama H, Yoshimoto D, Kaise T, Matsubara S, Fujiwara M, Kikkawa H, et al. Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis. Experimental and molecular pathology. 2007;83:39–46. doi: 10.1016/j.yexmp.2006.12.003. [DOI] [PubMed] [Google Scholar]
- 64.Chen SJ, Yuan W, Lo S, Trojanowska M, Varga J. Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta. Journal of cellular physiology. 2000;183:381–92. doi: 10.1002/(SICI)1097-4652(200006)183:3<381::AID-JCP11>3.0.CO;2-O. [DOI] [PubMed] [Google Scholar]
- 65.Ritzenthaler JD, Goldstein RH, Fine A, Lichtler A, Rowe DW, Smith BD. Transforming-growth-factor-beta activation elements in the distal promoter regions of the rat alpha 1 type I collagen gene. The Biochemical journal. 1991;280 (Pt 1):157–62. doi: 10.1042/bj2800157. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Rossi P, Karsenty G, Roberts AB, Roche NS, Sporn MB, de Crombrugghe B. A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta. Cell. 1988;52:405–14. doi: 10.1016/s0092-8674(88)80033-3. [DOI] [PubMed] [Google Scholar]
- 67.Majesky MW, Dong XR, Hoglund V, Mahoney WM, Jr, Daum G. The adventitia: a dynamic interface containing resident progenitor cells. Arteriosclerosis, thrombosis, and vascular biology. 2011;31:1530–9. doi: 10.1161/ATVBAHA.110.221549. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Solway J, Seltzer J, Samaha FF, Kim S, Alger LE, Niu Q, et al. Structure and expression of a smooth muscle cell-specific gene, SM22 alpha. The Journal of biological chemistry. 1995;270:13460–9. doi: 10.1074/jbc.270.22.13460. [DOI] [PubMed] [Google Scholar]
- 69.Lees-Miller JP, Heeley DH, Smillie LB, Kay CM. Isolation and characterization of an abundant and novel 22-kDa protein (SM22) from chicken gizzard smooth muscle. The Journal of biological chemistry. 1987;262:2988–93. [PubMed] [Google Scholar]
- 70.Li L, Miano JM, Cserjesi P, Olson EN. SM22 alpha, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circulation research. 1996;78:188–95. doi: 10.1161/01.res.78.2.188. [DOI] [PubMed] [Google Scholar]
- 71.Desguerre I, Mayer M, Leturcq F, Barbet JP, Gherardi RK, Christov C. Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation. Journal of neuropathology and experimental neurology. 2009;68:762–73. doi: 10.1097/NEN.0b013e3181aa31c2. [DOI] [PubMed] [Google Scholar]
- 72.Puchalski MD, Williams RV, Askovich B, Sower CT, Hor KH, Su JT, et al. Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy? The international journal of cardiovascular imaging. 2009;25:57–63. doi: 10.1007/s10554-008-9352-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Bostick B, Shin JH, Yue Y, Wasala NB, Lai Y, Duan D. AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy. Journal of molecular and cellular cardiology. 2012;53:217–22. doi: 10.1016/j.yjmcc.2012.05.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Matsuura K, Nagai T, Nishigaki N, Oyama T, Nishi J, Wada H, et al. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. The Journal of biological chemistry. 2004;279:11384–91. doi: 10.1074/jbc.M310822200. [DOI] [PubMed] [Google Scholar]
- 75.Wang X, Hu Q, Nakamura Y, Lee J, Zhang G, From AH, et al. The role of the sca-1+/CD31− cardiac progenitor cell population in postinfarction left ventricular remodeling. Stem cells (Dayton, Ohio) 2006;24:1779–88. doi: 10.1634/stemcells.2005-0386. [DOI] [PubMed] [Google Scholar]
- 76.Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, Mishina Y, et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proceedings of the National Academy of Sciences of the United States of America. 2003;100:12313–8. doi: 10.1073/pnas.2132126100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nature medicine. 2007;13:952–61. doi: 10.1038/nm1613. [DOI] [PubMed] [Google Scholar]
- 78.Huebner KD, Jassal DS, Halevy O, Pines M, Anderson JE. Functional resolution of fibrosis in mdx mouse dystrophic heart and skeletal muscle by halofuginone. American journal of physiology Heart and circulatory physiology. 2008;294:H1550–61. doi: 10.1152/ajpheart.01253.2007. [DOI] [PubMed] [Google Scholar]
- 79.Lorts A, Schwanekamp JA, Baudino TA, McNally EM, Molkentin JD. Deletion of periostin reduces muscular dystrophy and fibrosis in mice by modulating the transforming growth factor-beta pathway. Proceedings of the National Academy of Sciences of the United States of America. 2012;109:10978–83. doi: 10.1073/pnas.1204708109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Nelson CA, Hunter RB, Quigley LA, Girgenrath S, Weber WD, McCullough JA, et al. Inhibiting TGF-beta activity improves respiratory function in mdx mice. The American journal of pathology. 2011;178:2611–21. doi: 10.1016/j.ajpath.2011.02.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Van Erp C, Irwin NG, Hoey AJ. Long-term administration of pirfenidone improves cardiac function in mdx mice. Muscle & nerve. 2006;34:327–34. doi: 10.1002/mus.20590. [DOI] [PubMed] [Google Scholar]
- 82.Cucina A, Sterpetti AV, Borrelli V, Pagliei S, Cavallaro A, D’Angelo LS. Shear stress induces transforming growth factor-beta 1 release by arterial endothelial cells. Surgery. 1998;123:212–7. [PubMed] [Google Scholar]
- 83.Loufrani L, Matrougui K, Gorny D, Duriez M, Blanc I, Levy BI, et al. Flow (shear stress)-induced endothelium-dependent dilation is altered in mice lacking the gene encoding for dystrophin. Circulation. 2001;103:864–70. doi: 10.1161/01.cir.103.6.864. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Kamogawa Y, Biro S, Maeda M, Setoguchi M, Hirakawa T, Yoshida H, et al. Dystrophin-deficient myocardium is vulnerable to pressure overload in vivo. Cardiovascular research. 2001;50:509–15. doi: 10.1016/s0008-6363(01)00205-x. [DOI] [PubMed] [Google Scholar]
- 85.Wheeler MT, McNally EM. The interaction of coronary tone and cardiac fibrosis. Current atherosclerosis reports. 2005;7:219–26. doi: 10.1007/s11883-005-0010-8. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.